Wolters Kluwer Health completes the acquisition of Lexi-Comp

Wolters Kluwer Health has completed the acquisition of Lexi-Comp, a leading provider of drug information and clinical content for pharmacists, clinicians and hospitals internationally. The intent to acquire Lexi-Comp was previously reported on Fusion DigiNet. The acquisition is the latest in a series of strategic acquisitions Wolters Kluwer Health has made in its Clinical Solutions business as part of the company’s strong focus on the point-of-care market.

Arvind Subramanian, President & CEO of Wolters Kluwer Health Clinical Solutions said, “This acquisition is very much aligned with our growth strategy of building out our strong portfolio of Clinical Decision Support (CDS) solutions to further our leadership position in the point-of-care market. This strategy will enable our customers to access leading clinical content, drug information for the retail and hospital pharmacies and innovative mobile offerings.”

Lexi-Comp provides services and content to nearly 1,500 hospitals internationally, has more than 1,700 drug monographs and is particularly strong in the area of mobile content for pharmacists and clinicians. To support and supplement effective clinician-patient interactions, Lexi-Comp also provides patient medication leaflets in 19 languages. The company is headquartered nearCleveland, Ohio and has approximately 150 employees.

Terms of the acquisition were not disclosed.

USA, Philadelphia, PA

Related articles: